HomeAI · summaries
Storia in 2 fonti
Young startups miss out on biotech venture funding rebound, MassBio says
A new report found that the sizes of seed rounds and Series A financings for Massachusetts biotech startups are going in opposite directions, as funding slows for young companies with the “riskiest science.”
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Young startups miss out on biotech venture funding rebound, MassBio says
A new report found that the sizes of seed rounds and Series A financings for Massachusetts biotech startups are going in opposite directions, as funding slows for young companies…
- ·
statnews.com
After a years-long slump, Massachusetts biopharma sector has come roaring back in 2026
The number of people working in Massachusetts’ biotech sector fell last year, for the first time since at least 2002. But 2026 is looking up.